Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial.
Nyang'wa BT, Berry C, Kazounis E, Motta I, Parpieva N, Tigay Z, Moodliar R, Dodd M, Solodovnikova V, Liverko I, Rajaram S, Rassool M, McHugh T, Spigelman M, Moore DA, Ritmeijer K, du Cros P, Fielding K; TB-PRACTECAL team. Nyang'wa BT, et al. Among authors: ritmeijer k. Lancet Respir Med. 2024 Feb;12(2):117-128. doi: 10.1016/S2213-2600(23)00389-2. Epub 2023 Nov 16. Lancet Respir Med. 2024. PMID: 37980911 Free article. Clinical Trial.
High mortality among older patients treated with pentavalent antimonials for visceral leishmaniasis in East Africa and rationale for switch to liposomal amphotericin B.
Chappuis F, Alirol E, Worku DT, Mueller Y, Ritmeijer K. Chappuis F, et al. Among authors: ritmeijer k. Antimicrob Agents Chemother. 2011 Jan;55(1):455-6. doi: 10.1128/AAC.01298-10. Epub 2010 Nov 15. Antimicrob Agents Chemother. 2011. PMID: 21078947 Free PMC article. No abstract available.
Therapeutic Strategies against Leishmania and Trypanosoma.
Santos ALS, Rodrigues IA, d'Avila-Levy CM, Sodré CL, Ritmeijer K, Branquinha MH. Santos ALS, et al. Among authors: ritmeijer k. Pathogens. 2023 Oct 19;12(10):1263. doi: 10.3390/pathogens12101263. Pathogens. 2023. PMID: 37887779 Free PMC article.
Liposomal amphotericin B for the treatment of visceral leishmaniasis.
Bern C, Adler-Moore J, Berenguer J, Boelaert M, den Boer M, Davidson RN, Figueras C, Gradoni L, Kafetzis DA, Ritmeijer K, Rosenthal E, Royce C, Russo R, Sundar S, Alvar J. Bern C, et al. Among authors: ritmeijer k. Clin Infect Dis. 2006 Oct 1;43(7):917-24. doi: 10.1086/507530. Epub 2006 Aug 28. Clin Infect Dis. 2006. PMID: 16941377
Who is a typical patient with visceral leishmaniasis? Characterizing the demographic and nutritional profile of patients in Brazil, East Africa, and South Asia.
Harhay MO, Olliaro PL, Vaillant M, Chappuis F, Lima MA, Ritmeijer K, Costa CH, Costa DL, Rijal S, Sundar S, Balasegaram M. Harhay MO, et al. Among authors: ritmeijer k. Am J Trop Med Hyg. 2011 Apr;84(4):543-50. doi: 10.4269/ajtmh.2011.10-0321. Am J Trop Med Hyg. 2011. PMID: 21460007 Free PMC article.
Paromomycin.
Davidson RN, den Boer M, Ritmeijer K. Davidson RN, et al. Among authors: ritmeijer k. Trans R Soc Trop Med Hyg. 2009 Jul;103(7):653-60. doi: 10.1016/j.trstmh.2008.09.008. Epub 2008 Oct 23. Trans R Soc Trop Med Hyg. 2009. PMID: 18947845 Review.
Liposomal amphotericin B as a treatment for human leishmaniasis.
Balasegaram M, Ritmeijer K, Lima MA, Burza S, Ortiz Genovese G, Milani B, Gaspani S, Potet J, Chappuis F. Balasegaram M, et al. Among authors: ritmeijer k. Expert Opin Emerg Drugs. 2012 Dec;17(4):493-510. doi: 10.1517/14728214.2012.748036. Epub 2012 Nov 20. Expert Opin Emerg Drugs. 2012. PMID: 23167833 Free PMC article. Review.
95 results